home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

DNA Adopts A New Fold

 
  July, 26 2005 11:08
your information resource in human molecular genetics
 
     
A new structure formed by a DNA sequence that is known to be important in cancer development is reported in the August issue of Nature Chemical Biology. This structural information should help scientists develop a new range of anticancer drugs.

Human c-Myc is a transcription factor that is central to regulation of cell proliferation. The MYC gene in normal cells is tightly regulated and is only expressed when cells actively divide. In contrast, cancer cells may express the gene in an uncontrolled fashion. One particular region of MYC DNA, which controls up to 90% of its transcription, is composed of a purine-rich strand that adopts other biologically relevant structures beyond the Watson-Crick double helix. One such DNA structure, the G-quadruplex, is formed by the stacking of guanine tetrads, comprising four guanines arranged in a flat ring. Stabilization of G-quadruplex structures, by small-molecule ligands is known to decrease MYC expression levels.

Patel and coworkers used nuclear magnetic resonance spectroscopy to characterize an entirely new G-quadruplex structure of a five-guanine-tract MYC DNA sequence, in contrast to previous structures containing four-guanine-tract sequences. They also showed the structure of this new five-guanine-tract sequence in complex with a small-molecule porphyrin, which is known to stabilize G-quadruplex structures.

The authors suggest that the structural information derived from this and other small-molecule interactions with G-quadruplex structures will provide a platform for the development of a new class of anticancer compounds that target G-quadruplex DNA structures.

Author contacts:

Dinshaw J. Patel (Memorial Sloan-Kettering Cancer Center, New York, NY, USA)
E-mail: pateld@mskcc.org

Anh Tuan Phan (Memorial Sloan-Kettering Cancer Center, New York, NY, USA)
E-mail: phantuan@mskcc.org

Also published online.

(C) Nature Chemical Biology press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2017 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.